Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

COMMANDOR HF

Projekt: Typer af projekter

Vis graf over relationer
A randomized, double-blind, event-driven, multicenter study comparing the efficacy and safety of Rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an episode of decompensated heart failure.
StatusAfsluttet
Periode01/12/201531/12/2018

ID: 45890940